ConductScience.org, home

Paper39574178

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S and 9 others. Mol Cancer, 2024. Cited by 223 papers, by iCite.

Cite this record

ConductScience Library. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Papers, record 39574178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39574178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.
PubMed
Journal
Mol Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
223
iCite
Relative citation ratio, by iCite
30.8, provisional
iCite
Revised in PubMed
2026-06-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu SShan
2Zhang XXingda
3Wang WWenzheng
4Li XXue
5Sun XXue
6Zhao YYuqian
7Wang QQi
8Li YYingpu
9Hu FFangjie
10Ren HHe

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Drug Resistance, NeoplasmMajor topic
Neoplasm MetastasisMajor topic
Humans
Female
Animals
Tumor Microenvironment
Cellular Reprogramming
Antineoplastic Agents
Energy Metabolism
Metabolic Reprogramming

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2023-KYYWF-0202Harbin Medical UniversityPubMed

Source PubMed

Download CSV of grants

References680

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138169800Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy.Front Pharmacol2023https://conductscience.org/library/papers/38169800PubMed
231723000Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.Cancer Res2020https://conductscience.org/library/papers/31723000PubMed
330143015Association of tamoxifen resistance and lipid reprogramming in breast cancer.BMC Cancer2018https://conductscience.org/library/papers/30143015PubMed
417255361Inhibitory effect of tumor cell-derived lactic acid on human T cells.Blood2007https://conductscience.org/library/papers/17255361PubMed
536121176Chrysin targets myeloid-derived suppressor cells and enhances tumour response to anti-PD-1 immunotherapy.Clin Transl Med2022https://conductscience.org/library/papers/36121176PubMed
637996538Eph receptors and ephrins in cancer progression.Nat Rev Cancer2024https://conductscience.org/library/papers/37996538PubMed
737133969Tumor-Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma Immunotherapy.Adv Mater2023https://conductscience.org/library/papers/37133969PubMed
831629410Tumor-associated macrophages: an accomplice in solid tumor progression.J Biomed Sci2019https://conductscience.org/library/papers/31629410PubMed
930914826Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/30914826PubMed
1012142961Obesity and immunocompetence.Eur J Clin Nutr2002https://conductscience.org/library/papers/12142961PubMed
1132066951Distinct microbial and immune niches of the human colon.Nat Immunol2020https://conductscience.org/library/papers/32066951PubMed
1237242217Long-Term Effects of a Ketogenic Diet for Cancer.Nutrients2023https://conductscience.org/library/papers/37242217PubMed
1324812208The cellular and molecular origin of tumor-associated macrophages.Science2014https://conductscience.org/library/papers/24812208PubMed
1433546704The cancer metabolic reprogramming and immune response.Mol Cancer2021https://conductscience.org/library/papers/33546704PubMed
1533669775Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/33669775PubMed
1638507720A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.Cancer Res2024https://conductscience.org/library/papers/38507720PubMed
1730262472Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.Science2018https://conductscience.org/library/papers/30262472PubMed
1831852848Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues.JCI Insight2019https://conductscience.org/library/papers/31852848PubMed
1933408816Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.J Extracell Vesicles2020https://conductscience.org/library/papers/33408816PubMed
2030051890Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.Nature2018https://conductscience.org/library/papers/30051890PubMed

See all 680 referencesDownload CSV of references

Cited by175

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.

PMIDTitleJournalYearIn PapersSource
42988793SWI/SNF subunit SMARCD1 deficiency promotes clear cell renal cell carcinoma progression via mitochondrial reprogramming.Nat Commun2026https://conductscience.org/library/papers/42988793PubMed
42964571Breast cancer adaptation to oxygen stress: mechanisms of tumor survival, progression, and therapeutic resistance.Oncol Rev2026https://conductscience.org/library/papers/42964571PubMed
42964275Addressing unmet clinical needs in treatment-resistant breast cancer: expanding the diagnostic-prognostic landscape through next-generation inflammatory signatures.Oncol Rev2026https://conductscience.org/library/papers/42964275PubMed
42939881Therapeutic Redox Reprogramming in Breast Cancer: From Antioxidant Modulation to Precision Nanomedicine.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939881PubMed
42910173Identification of Immuno-Diagnostic and Therapeutic Markers in Tumors and Inflammatory Diseases Based on Single-Cell and Machine Learning Methods.Hum Mutat2026https://conductscience.org/library/papers/42910173PubMed
42874536NR3C2 suppresses triple-negative breast cancer progression by regulating mitochondrial ROS homeostasis via NDUFB3.Transl Oncol2026https://conductscience.org/library/papers/42874536PubMed
42855711RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.Biomark Res2026https://conductscience.org/library/papers/42855711PubMed
42827658Cancer Cell Metastasis: From Molecular Mechanisms to Therapeutic Strategies.MedComm (2020)2026https://conductscience.org/library/papers/42827658PubMed
42798757Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance.Front Oncol2026https://conductscience.org/library/papers/42798757PubMed
42789583
Integrative computational analysis of public fecal lipidomics and transcriptomics datasets suggests a candidate association between the COX-2 pathway and CE(20:4) in colorectal adenoma-carcinoma progression.
PLoS One2026https://conductscience.org/library/papers/42789583PubMed
42780345The mechanism of breast cancer stem cells and tumor microenvironment promoting radioresistance in breast cancer and its intervention strategies.Front Immunol2026https://conductscience.org/library/papers/42780345PubMed
42778549Heterogeneity in cancer: molecular mechanisms and therapeutic strategies.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42778549PubMed
42776318SUCLG2 contributes to platinum resistance in lung adenocarcinoma through enhancing succinylation of GAC and glutamine metabolism.Apoptosis2026https://conductscience.org/library/papers/42776318PubMed
42758515Pyrroline-5-carboxylate reductase 1 interacts with Nudix hydrolase 5 to drive bladder cancer malignant progression via activation of the APOE/JAK2/STAT3 signalling axis.Clin Transl Med2026https://conductscience.org/library/papers/42758515PubMed
42756460Immune evasion driven by lipid metabolic reprogramming in endocrine-resistant HR+ breast cancer: antigen presentation defects and T-cell dysfunction.Front Immunol2026https://conductscience.org/library/papers/42756460PubMed
42746350Microbiota-driven metabolic-immune crosstalk in breast cancer.Front Pharmacol2026https://conductscience.org/library/papers/42746350PubMed
42733578ENO1 as a potential tumor prognostic marker promotes the proliferation, invasion, and metastasis of breast cancer cells.Genes Dis2027https://conductscience.org/library/papers/42733578PubMed
42712410Therapeutic potential and molecular mechanisms of citrus flavonoids in hepatocellular carcinoma.Front Pharmacol2026https://conductscience.org/library/papers/42712410PubMed
42694955Targeting Folate Receptors for the Detection and Selective Treatment of Cancer: Advanced Precision Oncology in Practice.Int J Biol Sci2026https://conductscience.org/library/papers/42694955PubMed
42657117Glycolytic reprogramming in precancerous lesions of gastric cancer progression: pathogenesis and therapeutic potential.Front Oncol2026https://conductscience.org/library/papers/42657117PubMed

See all 175 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39574178

GET https://conductscience.org/api/papers/v1/39574178/references?page=2